The Latest Cardiac and Vascular News
HOLLYWOOD, Fla.–(BUSINESS WIRE)–Dassault Systèmes (Paris:DSY) (Euronext Paris: #13065, DSY.PA) today outlined, at the 3DEXPERIENCE Forum North America, multiple milestones in its Living Heart Project aimed to drive the creation and use of simulated 3D personalized hearts in the treatment, diagnosis and prevention of heart diseases. As the scientific and medical community seeks faster and more targeted […]
By Ken Dropiewski, Prime-Core Executive Search (ken@prime-core.com) According to MedAxiom’s annual Cardiovascular Provider Compensation & Production survey 45 percent of all cardiologists in America are aged 56 or older and 20 percent over 61. So, with an aging population of cardiology practitioners we must ask, “how is this is being addressed?” Two […]
October 16, 2017 Rebecca Anderson Technology has the potential to revolutionise emergency department triage of chest pain patients. Developer of innovative medical diagnostic technology, Creavo Medical Technologies, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The move opens the U.S. market for its portable scanning device, Vitalscan, […]
BURLINGTON, Mass., Oct. 16, 2017 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2017 financial results on Thursday, October 26, 2017, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and […]
TORONTO, Oct. 17, 2017 /PRNewswire/ – Baylis Medical Company Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at helping cardiologists perform a complex procedure that is quickly becoming the gold standard for treating patients with atrial fibrillation and other structural heart diseases. The two companies are working with […]
Study Evaluates Patients With Kidney Disease After Undergoing TAVR By Cardiac Interventions Today October 16, 2017—The American College of Cardiology (ACC) announced the publication of a study demonstrating a relatively low rate of patients with chronic kidney disease undergoing transcatheter aortic valve replacement (TAVR) who eventually need to start dialysis. […]
SAN DIEGO, Oct. 16, 2017 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) announced today the commercial expansion of its bioresorbable scaffold (“BRS”), Fantom®, with the first implant in Switzerland. The first implant of Fantom in Switzerland was conducted at Kantonsspital Baselland in Liestal, Switzerland by Dr. Gregor Leibundgut. “Following my […]
GALWAY, Ireland–(BUSINESS WIRE)–Vivasure Medical® (“Vivasure”) is pleased to announce the successful enrollment of the first patient in the Frontier IV clinical study, a non-randomized multicenter international trial, designed to expand the indications of its proprietary PerQseal® large arteriotomy closure technology. The patient was enrolled by Dr. Peter Crean at the […]
CHICAGO, Oct. 13, 2017 /PRNewswire/ — Bioprinting startup BIOLIFE4D named accomplished thoracic and cardiac surgeon Jeffrey Morgan M.D., FACS, FACC as Chief Medical Officer, further bolstering its world-class leadership team. BIOLIFE4D is a pioneering biotech company focused on leveraging advances in life sciences and tissue engineering to 3D bioprint a viable human heart suitable for transplant. Joining […]
Boston Scientific shared the 3-year MAJESTIC DES data online at CardioVascular and Interventional Radiology MAJESTIC 3-Year Data Published for Boston Scientific’s Eluvia DES, by Endovascular Today October 11, 2017—The 3-year results of the MAJESTIC first-in-human study of the Eluvia paclitaxel-eluting vascular stent system (Boston Scientific) for treating femoropopliteal artery lesions were published […]
